

AiXin Life International has filed proposed terms for a $7 million U.S. IPO. The firm sells vitamins and other supplements for the Chinese market. AIXN has produced uneven results, has significant risks operating in China and the IPO appears excessively priced.

CHENGDU, CHINA, June 07, 2021 (GLOBE NEWSWIRE) -- AiXin Life International, Inc. (OTCQX: AIXN) (hereinafter referred to as “AIXN” or the “Company”), on May 25, 2021, agreed to purchase the Shangyan Hotel located in Chengdu, for a purchase price of approximately $1.2 million. On June 2, 2021, the Company agreed to purchase a chain of nine pharmacies also located in Chengdu for an aggregate purchase price of approximately $5.3 million.

NEW YORK, Jan. 22, 2021 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced AiXin Life International, Inc. (OTCQX: AIXN), focused on providing nutritional products in China and advertising and marketing...